Press Releases

Date	Title	PDF Version
Oct 27, 2010	Alexion to Present at the Oppenheimer 21st Annual Healthcare Conference
Oct 21, 2010	Alexion Reports Third Quarter 2010 Results
Oct 20, 2010	Alexion Announces Interim Results from Phase 2 Trials of Eculizumab (Soliris(R)) in Patients with atypical Hemolytic Uremic Syndrome (aHUS)
Oct 07, 2010	Alexion Pharmaceuticals to Report Third Quarter Results on Thursday, October 21, 2010
Sep 27, 2010	Alexion Pharmaceuticals Earns the Connecticut Green Building Council Green Advocate Award and Two LEED Gold Certifications for Environmental Sustainability
Sep 14, 2010	Alexion to Present at the UBS Global Life Sciences Conference
Sep 07, 2010	Alexion to Present at Investor Conferences
Aug 23, 2010	Alexion Receives FDA Approval of Rhode Island Manufacturing Facility for Soliris(R) Supply
Jul 22, 2010	Alexion Reports Second Quarter 2010 Results
Jul 12, 2010	Alexion Pharmaceuticals to Report Second Quarter Results on Thursday, July 22, 2010

Search